|
C12ORF49 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.03269999721201E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.460700E-03 |
| Normal-vs-Stage2 |
4.155100E-04 |
| Normal-vs-Stage3 |
8.29447621697454E-13 |
| Normal-vs-Stage4 |
7.219700E-03 |
| Stage1-vs-Stage2 |
1.784170E-01 |
| Stage1-vs-Stage3 |
1.51783999999822E-05 |
| Stage1-vs-Stage4 |
1.248600E-01 |
| Stage2-vs-Stage3 |
7.825600E-02 |
| Stage2-vs-Stage4 |
5.430600E-01 |
| Stage3-vs-Stage4 |
7.238000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.27800000874146E-09 |
| Normal-vs-AfricanAmerican |
1.006420E-01 |
| Normal-vs-Asian |
9.740400E-01 |
| Caucasian-vs-AfricanAmerican |
5.817600E-01 |
| Caucasian-vs-Asian |
2.723400E-01 |
| AfricanAmerican-vs-Asian |
5.609400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.02140518265514E-14 |
| Normal-vs-Female |
2.931400E-01 |
| Male-vs-Female |
3.238000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.379800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.611600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.43799971930036E-10 |
| Normal-vs-Age(81-100Yrs) |
3.135200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.092000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.167800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.378000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.340220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.795400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.943800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.173800E-01 |
| Normal-vs-Grade 2 |
3.802300E-04 |
| Normal-vs-Grade 3 |
7.83380000000111E-05 |
| Normal-vs-Grade 4 |
1.02307051719208E-12 |
| Grade 1-vs-Grade 2 |
1.219150E-01 |
| Grade 1-vs-Grade 3 |
1.393960E-01 |
| Grade 1-vs-Grade 4 |
1.060230E-02 |
| Grade 2-vs-Grade 3 |
2.293600E-01 |
| Grade 2-vs-Grade 4 |
4.17320000001276E-06 |
| Grade 3-vs-Grade 4 |
6.144000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.219900E-02 |
| Normal-vs-ccB subtype |
4.85090001500765E-09 |
| ccA subtype-vs-ccB subtype |
1.60438999999846E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.17090000001574E-06 |
| Normal-vs-N1 |
1.172110E-02 |
| N0-vs-N1 |
2.750400E-01 |
|
|
